Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease (Q21262018)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease |
scientific article |
Statements
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease (English)
0 references
2 references
Leah R Hanson
1 reference
William H Frey
1 reference
10 December 2008
10 references
19 March 2019
22 March 2019
25 April 2019
17 June 2019
25 June 2019
12 September 2019
10 October 2019
16 October 2020
26 October 2020
15 July 2021
11 references
19 March 2019
22 March 2019
25 April 2019
17 June 2019
25 June 2019
12 September 2019
10 October 2019
1 June 2020
16 October 2020
26 October 2020
15 July 2021
9 Suppl 3
0 references
Suppl 3
0 references
S5
0 references
10 references
19 March 2019
22 March 2019
25 April 2019
17 June 2019
25 June 2019
12 September 2019
10 October 2019
16 October 2020
26 October 2020
15 July 2021
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference